FdaApplication
NDA 021749
Identifiers
- fda_app_no: NDA021749
Properties
| Property | Value |
|---|---|
| applicant_name | HAMELN PHARMA GMBH |
| application_type | NDA |
| approval_date | 2004-08-11 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PENTETATE CALCIUM TRISODIUM | PENTETATE CALCIUM TRISODIUM | EQ 1GM BASE/5ML (EQ 200MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;INHALATION, INTRAVENOUS |
1 product